These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 7782424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Source localization of androgen excess in adolescent girls.
    Ibáñez L, Potau N, Zampolli M, Prat N, Gussinyé M, Saenger P, Vicens-Calvet E, Carrascosa A.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
    [Abstract] [Full Text] [Related]

  • 3. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM, Angioni S, Belosi C, Apa R, Selvaggi L, Ciampelli M, Iuculano A, Melis GB, Lanzone A.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL, Barnes RB, Ehrmann DA.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [Abstract] [Full Text] [Related]

  • 8. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
    Cheung AP, Pride SM, Yuen BH, Sy L.
    Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525
    [Abstract] [Full Text] [Related]

  • 9. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ.
    N Engl J Med; 1996 Aug 29; 335(9):617-23. PubMed ID: 8687515
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
    Catteau-Jonard S, Bancquart J, Poncelet E, Lefebvre-Maunoury C, Robin G, Dewailly D.
    Ultrasound Obstet Gynecol; 2012 Aug 29; 40(2):223-9. PubMed ID: 22648908
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep 29; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.